Results 121 to 130 of about 5,939 (161)

Eosinophilic Granulomatosis with Polyangiitis that Manifested after Administration of Benralizumab in a Patient with Refractory Recurrent Bronchial Asthma. [PDF]

Intern Med
Yamamoto U, Oba Y, Rikihisa T, Taniguchi S, Mizuno H, Sekine A, Yamanouchi M, Hasegawa E, Suwabe T, Tamaoka M, Takaya H, Kono K, Ohashi K, Wada T, Sawa N, Ubara Y.   +15 more
europepmc   +1 more source

Burden of eosinophilic granulomatosis with polyangiitis by disease phase and steroid-sparing effects of biologics: a real-world retrospective study in Europe. [PDF]

ERJ Open Res
Hwee J, Huynh L, Alfonso-Cristancho R, da Costa W, Duh MS, Pongdee T.   +5 more
europepmc   +1 more source

Eosinophilic Granulomatosis With Polyangiitis Presenting as Mononeuritis Multiplex in a Diabetic Patient: Diagnostic and Therapeutic Challenges. [PDF]

Cureus
Ahmed W, Khan MZ, Saeed R, Nazir K, Farooq M.   +4 more
europepmc   +1 more source

Effectiveness of low-dose mepolizumab in refractory eosinophilic granulomatosis with polyangiitis: systemic steroid use and remission. [PDF]

Korean J Intern Med
Kim MA, Lee JH, Kim EK, Kim JH, Park J, Lee SH, Kim TB.   +6 more
europepmc   +1 more source

From Anti-Neutrophil Cytoplasmic Antibody-Negative to Positive: Eosinophilic Granulomatosis with Polyangiitis Under Benralizumab After Steroid Cessation. [PDF]

J Clin Pract Res
Işık Ş, Yılmaz İ, Türk M, Açar E, Pektaş Alpsoy H.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Eosinophilic granulomatosis with polyangiitis

Medicina Clínica (English Edition), 2023
Eosinophilic granulomatosis with polyangiitis (EGPA) is a systemic vasculitis characterized by the presence of asthma associated with eosinophilia, eosinophilic infiltration of different organs, and vasculitis of small and medium-sized vessels. Although classified as anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis, it occurs in less ...
Carlos, Romero Gómez, Halbert, Hernández Negrín, María Del Mar, Ayala Gutiérrez   +2 more
  +7 more sources

Mepolizumab for the treatment of eosinophilic granulomatosis with polyangiitis

Expert Opinion on Biological Therapy, 2019
Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis characterized by asthma, hypereosinophilia, and progressive multiorgan involvement. Although not fully elucidated, advancement in our understanding of the pathophysiology of EGPA has led to the development of multiple new ...
, Daniel Ennis
exaly   +3 more sources

Biologics for eosinophilic granulomatosis with polyangiitis

Current Opinion in Allergy & Clinical Immunology, 2022
Purpose of review The link between severe asthma and eosinophilic granulomatosis with polyangiitis (EGPA) in terms of pathophysiological background, clinical manifestations and disease evolution has leaded to investigate the relevance of anti T2 monoclonal antibodies licensed for severe asthma patients as a treatment option for
Caminati, Marco, Maule, Matteo, Bello, Federica, Emmi, Giacomo   +3 more
openaire   +4 more sources